Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122674) titled '18F-Pentixafor PET in Hematologic Malignancies' on Aug. 7.
Study Type: Observational
Primary Sponsor: First Affiliated Hospital of Zhejiang University
Condition:
Hematological Malignancies
Intervention:
Drug: 18F-Pentixafor
Recruitment Status: Recruiting
Date of First Enrollment: July 1, 2025
Target Sample Size: 100
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122674
Published by HT Digital Content Services with permission from Health Daily Digest....